Jim Cramer answers viewers' Twitter (TWTR) questions on Monday from the floor of the New York Stock Exchange. When one viewer asks if Cramer foresees a surge coming in Netflix (NFLX) or if he should get out of his position, Cramer says while he does think he stock can still go higher, it already has had a bit of a surge. While he likes the company, Cramer stresses investors should be aware of the fact that the stock has already had a very big move. Shares of Netflix can still go higher, he says, but warns not to expect the stock to double or anything significant like that. Another viewer who has been holding shares of Groupon (GRPN) since $30 asks if he should add to his position, sell out of it or continue to hold. Cramer says there's 'no edge' to Groupon, and the company is trying to figure itself out. That's not usually a very good position for a company to be in, according to Cramer. He also responds to a viewer looking for insight on Allergan's (AGN) stock price through the end of the year. He says he expects that Allergan, which he owns in his Action Alerts PLUS charitable trust portfolio, can easily go up $50. He calls it one of his 'absolute favorites' and reveals how to play it. If you have a stock question, tweet it @jimcramer using #CramerQ.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.